Apollo AI Technologies

Apollo Technologies was founded in 2022 to put patients at the center of healthcare and simplify a complex and bureaucratic system.

Using artificial intelligence, the company provides doctors and pharmacists with tools that improve efficiency and accessibility.

The company refines its solutions based on real-world feedback from doctors and pharmacists. By combining advanced technology with practical medical needs, Apollo Technologies delivers reliable, regulatory-compliant solutions that optimize clinical decisions and improve patient care.

The main products are Diabeta, a digital solution for diabetologists, Pharmachat and Chat4Doc, which support healthcare professionals in making treatment decisions.

Diabeta is an AI-based digital solution designed to support diabetologists with instant access to official protocols, treatment guidelines and drug interactions. It simplifies access to essential information, reducing administrative burdens and the risk of errors. It also integrates adverse reaction reporting, ensuring regulatory compliance. Through secure access, physicians can receive real-time answers, improving efficiency and patient care. Diabeta optimizes clinical decision-making and makes essential medical data easily accessible, contributing to better outcomes for patients with diabetes.

1) Innovation Ecosystem

  • Support for partnership development – exposure to events and opportunity identification;
  • Support for VInnovate partnerships – Digital resource platform (gateway) report (a shortlist of potential partners from other VInnovate regions – profile in Gateway and other tools made available online by VInnovate) + International Tech Synergy Services (international matchmaking).

2) Test before invest

  • Assessment of the level of digital maturity;
  • Support for digitalization project implementation – consultancy;
  • Detailed analysis of needs and requirements for innovative solution development;
  • Technology maturity assessment (TRL) – detailed report useful for application in national/regional R&D calls;
  • Access to testing/validation/prototyping infrastructure and expertise (DTE full) for prototype testing and validation.

3) Access to finance

  • Support for accessing non-reimbursable financing;
  • Grant readiness workshop to complete the fitform, develop a business plan, mentoring and consulting for access to funding.

4) Digital culture & skills

  • Micro-training: Product Manager, Networks – data security, Python for artificial intelligence, Development of skills to use the European Commission platform.